Reserpine
Internal ID | c8bfc55c-1336-401b-8dd6-930b3d8cf379 |
Taxonomy | Alkaloids and derivatives > Yohimbine alkaloids |
IUPAC Name | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
SMILES (Canonical) | COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC |
SMILES (Isomeric) | CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC |
InChI | InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1 |
InChI Key | QEVHRUUCFGRFIF-MDEJGZGSSA-N |
Popularity | 28,397 references in papers |
Molecular Formula | C33H40N2O9 |
Molecular Weight | 608.70 g/mol |
Exact Mass | 608.27338086 g/mol |
Topological Polar Surface Area (TPSA) | 118.00 Ų |
XlogP | 4.00 |
Atomic LogP (AlogP) | 4.17 |
H-Bond Acceptor | 10 |
H-Bond Donor | 1 |
Rotatable Bonds | 8 |
50-55-5 |
Serpalan |
Serpasil |
Apoplon |
Serpivite |
Alserin |
Hypersil |
Sandril |
Deserpine |
Elserpine |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9136 | 91.36% |
Caco-2 | - | 0.7212 | 72.12% |
Blood Brain Barrier | + | 1.0000 | 100.00% |
Human oral bioavailability | - | 0.8000 | 80.00% |
Subcellular localzation | Mitochondria | 0.6614 | 66.14% |
OATP2B1 inhibitior | + | 1.0000 | 100.00% |
OATP1B1 inhibitior | - | 0.7738 | 77.38% |
OATP1B3 inhibitior | - | 0.5699 | 56.99% |
MATE1 inhibitior | - | 0.7800 | 78.00% |
OCT2 inhibitior | - | 0.6389 | 63.89% |
BSEP inhibitior | + | 0.9859 | 98.59% |
P-glycoprotein inhibitior | + | 0.9026 | 90.26% |
P-glycoprotein substrate | + | 0.8392 | 83.92% |
CYP3A4 substrate | + | 0.6235 | 62.35% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | + | 0.4057 | 40.57% |
CYP3A4 inhibition | - | 0.8310 | 83.10% |
CYP2C9 inhibition | - | 0.9071 | 90.71% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | - | 0.9384 | 93.84% |
CYP1A2 inhibition | + | 0.8965 | 89.65% |
CYP2C8 inhibition | + | 0.7224 | 72.24% |
CYP inhibitory promiscuity | - | 0.7062 | 70.62% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5756 | 57.56% |
Eye corrosion | - | 0.9906 | 99.06% |
Eye irritation | - | 0.9540 | 95.40% |
Skin irritation | - | 0.8037 | 80.37% |
Skin corrosion | - | 0.9538 | 95.38% |
Ames mutagenesis | - | 0.9500 | 95.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.9354 | 93.54% |
Micronuclear | - | 0.6500 | 65.00% |
Hepatotoxicity | - | 0.9875 | 98.75% |
skin sensitisation | - | 0.9087 | 90.87% |
Respiratory toxicity | + | 0.9889 | 98.89% |
Reproductive toxicity | + | 0.9889 | 98.89% |
Mitochondrial toxicity | + | 0.9875 | 98.75% |
Nephrotoxicity | - | 0.8250 | 82.50% |
Acute Oral Toxicity (c) | II | 0.7393 | 73.93% |
Estrogen receptor binding | + | 0.8906 | 89.06% |
Androgen receptor binding | + | 0.8697 | 86.97% |
Thyroid receptor binding | + | 0.6241 | 62.41% |
Glucocorticoid receptor binding | + | 0.8684 | 86.84% |
Aromatase binding | + | 0.8685 | 86.85% |
PPAR gamma | + | 0.8370 | 83.70% |
Honey bee toxicity | - | 0.7417 | 74.17% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | - | 0.5349 | 53.49% |
Fish aquatic toxicity | + | 0.7635 | 76.35% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
19952.6 nM 39810.7 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
19952.6 nM |
Potency |
via CMAUP
|
CHEMBL5393 | Q9UNQ0 | ATP-binding cassette sub-family G member 2 |
26302.68 nM |
IC50 |
PMID: 18678495
|
CHEMBL1293237 | P54132 | Bloom syndrome protein |
17782.8 nM 17782.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4801 | P29466 | Caspase-1 |
7943.3 nM |
Potency |
via CMAUP
|
CHEMBL3468 | P55210 | Caspase-7 |
7943.3 nM |
Potency |
via CMAUP
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
3981.1 nM 3981.1 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2392 | P06746 | DNA polymerase beta |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL1293278 | O75496 | Geminin |
11220.2 nM |
Potency |
via CMAUP
|
CHEMBL4331 | P68871 | Hemoglobin beta chain |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL1293299 | Q03164 | Histone-lysine N-methyltransferase MLL |
28183.8 nM |
Potency |
via CMAUP
|
CHEMBL1287622 | Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 |
28183.8 nM |
Potency |
via CMAUP
|
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
22387.2 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
7943.3 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
14125.4 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL233 | P35372 | Mu opioid receptor |
4152 nM |
IC50 |
via CMAUP
|
CHEMBL5162 | Q6W5P4 | Neuropeptide S receptor |
10000 nM |
Potency |
via CMAUP
|
CHEMBL4302 | P08183 | P-glycoprotein 1 |
2100 nM 500 nM 2100 nM 2600 nM 3900 nM 5300 nM 3235.94 nM 6100 nM 3019.95 nM 3235.94 nM |
IC50 IC50 IC50 IC50 IC50 IC50 IC50 IC50 IC50 IC50 |
PMID: 11716514
PMID: 11716514 PMID: 11716514 PMID: 11716514 PMID: 11716514 PMID: 11716514 PMID: 18678495 PMID: 11716514 PMID: 17890094 PMID: 17890094 |
CHEMBL1293298 | Q01453 | Peripheral myelin protein 22 |
47754.8 nM |
Potency |
via CMAUP
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
17782.8 nM |
Potency |
via CMAUP
|
CHEMBL1893 | Q05940 | Synaptic vesicular amine transporter |
5.26 nM |
Ki |
via Super-PRED
|
CHEMBL1293256 | P40225 | Thrombopoietin |
31622.8 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
44668.4 nM 56234.1 nM 10000 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL4302 | P08183 | P-glycoprotein 1 | 98.78% | 92.98% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.63% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.18% | 91.11% |
CHEMBL2535 | P11166 | Glucose transporter | 96.14% | 98.75% |
CHEMBL5747 | Q92793 | CREB-binding protein | 95.03% | 95.12% |
CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 93.89% | 91.79% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.55% | 95.56% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 91.39% | 93.99% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 91.35% | 94.00% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.09% | 99.17% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.95% | 97.09% |
CHEMBL4208 | P20618 | Proteasome component C5 | 89.55% | 90.00% |
CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 88.36% | 90.95% |
CHEMBL5697 | Q9GZT9 | Egl nine homolog 1 | 88.12% | 93.40% |
CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 86.00% | 97.03% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 85.28% | 91.19% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 84.67% | 86.33% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 82.86% | 95.89% |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 82.50% | 95.56% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 81.88% | 92.62% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.73% | 99.23% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.70% | 95.89% |
CHEMBL1907 | P15144 | Aminopeptidase N | 80.18% | 93.31% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 80.13% | 97.28% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 80.04% | 94.45% |
CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.01% | 82.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.